top of page

Saudi Arabia’s (SFDA): Requirements on Importation and Shipments of Medical Devices (MDS-REQ5)

Writer's picture: Sharan MuruganSharan Murugan

Earlier today (21 May 2023) to ensure the importation and shipment of medical devices comply with rigorous standards, the Saudi Food and Drug Authority (SFDA) issued a comprehensive guidance document titled "Requirements on Importation and Shipments of Medical Devices (MDS-REQ5)".

Guidance is only available in Arabic (The English version is not available at the moment).


Medical device manufacturers, importers, and other stakeholders will be able to rely on this latest guidance to ensure that their products comply with the necessary regulatory requirements to ensure public health.


As described in the SFDA's MDS-REQ5 guidance, the importation and shipping of medical devices into Saudi Arabia must follow certain steps and requirements.


The primary goal is to offer healthcare providers and patients only safe, effective, and reliable medical devices.


Detailed information such as Licensing and Registration, Technical Documentation, labeling and Packaging, Quality Management System, Post-Market Surveillance, etc. are captured exclusively in this document.


By adhering to these requirements, the SFDA aims to safeguard public health, mitigate risks, and maintain high standards throughout the supply chain.


As the SFDA continues to prioritize the well-being of its citizens, this guide will serve as a cornerstone for a robust regulatory framework that adapts to the evolving landscape of medical devices.





Comments


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page